FDA-Drug2026-04-22Class II
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
PAYLESS COMPOUNDERS, LLC
Hazard
Lack of Assurance of Sterility
Sold states
OR
Affected count
91 vials
Manufactured in
8505 Sw Creekside Pl Ste 110, N/A, Beaverton, OR, United States
Products
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0471-2026Original summary
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR Lack of Assurance of Sterility Lot Number 01-27-2026@14S.5 Distribution: OR Affected quantity: 91 vials
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief